Literature DB >> 18370652

Asian indians and insulin resistance syndrome: global perspective.

Anoop Misra, Ranjita Misra.   

Abstract

Insulin resistance syndrome (IRS) is a crucial factor in causation of type 2 diabetes mellitus (T2DM) in Asian Indians. Approximately one-fifth of the migrant Asian Indians have evidence of metabolic syndrome. Furthermore, insulin resistance as estimated by homeostatic model assessment (HOMA-IR) was reported to be present in one-fifth of children and young adult Asian Indians with normal body mass index (BMI) and ~45-67% of those having high BMI. The cause(s) of such high prevalence of IRS in Asian Indians is not clear; however, inherent genetic predisposition, physical inactivity, excess regional body fat, and factors associated with migration may play an important role. It is important that lifestyle factor modification to prevent IRS and T2DM in Asian Indians should start in early childhood.

Entities:  

Year:  2003        PMID: 18370652     DOI: 10.1089/1540419031361390

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  12 in total

Review 1.  Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.

Authors:  Ajay Duseja; Shivaram P Singh; Vivek A Saraswat; Subrat K Acharya; Yogesh K Chawla; Subhankar Chowdhury; Radha K Dhiman; Rohinivilasam V Jayakumar; Kaushal Madan; Sri P Misra; Hrudananda Mishra; Sunil K Modi; Arumugam Muruganathan; Banshi Saboo; Rakesh Sahay; Rajesh Upadhyay
Journal:  J Clin Exp Hepatol       Date:  2015-03-06

Review 2.  Nonalcoholic fatty liver disease in India - a lot done, yet more required!

Authors:  Ajay Duseja
Journal:  Indian J Gastroenterol       Date:  2010-12-30

3.  Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD).

Authors:  Ajay Duseja; Naga Chalasani
Journal:  Hepatol Int       Date:  2013-11-02       Impact factor: 6.047

4.  Non-alcoholic Fatty Liver Disease: East Versus West.

Authors:  Swastik Agrawal; Ajay K Duseja
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

5.  Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia-A Prospective, Interventional, Pilot Study.

Authors:  N A Rajesh; L Drishya; Murali Mohan Raju Ambati; Athi L Narayanan; Maria Alex; Kiran Kumar R; Justin J Abraham; T M Vijayakumar
Journal:  J Clin Exp Hepatol       Date:  2021-04-09

6.  Association of metabolic syndrome with obesity measures, metabolic profiles, and intake of dietary fatty acids in people of Asian Indian origin.

Authors:  Mithun Das; Susil Pal; Arnab Ghosh
Journal:  J Cardiovasc Dis Res       Date:  2010-07

7.  A cross-sectional investigation of regional patterns of diet and cardio-metabolic risk in India.

Authors:  Carrie R Daniel; Dorairaj Prabhakaran; Kavita Kapur; Barry I Graubard; Niveditha Devasenapathy; Lakshmy Ramakrishnan; Preethi S George; Hemali Shetty; Leah M Ferrucci; Susan Yurgalevitch; Nilanjan Chatterjee; K S Reddy; Tanuja Rastogi; Prakash C Gupta; Aleyamma Mathew; Rashmi Sinha
Journal:  Nutr J       Date:  2011-01-28       Impact factor: 3.271

8.  A study of insulin resistance and its clinico-metabolic associations among apparently healthy individuals attending a tertiary care hospital.

Authors:  R Banerjee; K Ray; S Bhattacherjee; S Guha; I Banerjee; I Nath
Journal:  Ann Med Health Sci Res       Date:  2014-09

9.  Prevalence of metabolic syndrome in pre- and post-menopausal women: A prospective study from apex institute of North India.

Authors:  Sandeep Sharma; Neelam Aggarwal; Bharti Joshi; Vanita Suri; Sanjay Badada
Journal:  J Midlife Health       Date:  2016 Oct-Dec

10.  Risk factors for low high-density lipoprotein among Asian Indians in the United States.

Authors:  Brandon Lucke-Wold; Ranjita Misra; Thakor G Patel
Journal:  World J Diabetes       Date:  2017-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.